Variant report
Variant | nsv528548 |
---|---|
Chromosome Location | chr5:5050830-5060591 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:39)
- CpG islands (count:61)
- Chromatin interactive region (count:2)
- LncRNA region (count:18)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:39 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr5:5054207-5054499 | HepG2 | liver: | n/a | chr5:5054458-5054475 chr5:5054335-5054348 chr5:5054336-5054347 |
2 | CEBPB | chr5:5054323-5054376 | H1-hESC | embryonic stem cell: | n/a | chr5:5054335-5054348 chr5:5054336-5054347 |
3 | CEBPB | chr5:5054165-5054411 | A549 | lung: | n/a | chr5:5054335-5054348 chr5:5054336-5054347 |
4 | CEBPB | chr5:5054219-5054457 | K562 | blood: | n/a | chr5:5054335-5054348 chr5:5054336-5054347 |
5 | CTCF | chr5:5056647-5056696 | ProgFib | skin: | n/a | n/a |
6 | E2F4 | chr5:5055988-5056289 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | EP300 | chr5:5056587-5056695 | GM12878 | blood: | n/a | n/a |
8 | FOS | chr5:5051043-5051266 | MCF10A-Er-Src | breast: | n/a | chr5:5051124-5051132 chr5:5051123-5051133 chr5:5051122-5051134 chr5:5051123-5051133 chr5:5051123-5051133 chr5:5051123-5051133 |
9 | FOS | chr5:5051003-5051306 | MCF10A-Er-Src | breast: | n/a | chr5:5051124-5051132 chr5:5051123-5051133 chr5:5051122-5051134 chr5:5051123-5051133 chr5:5051123-5051133 chr5:5051123-5051133 |
10 | FOS | chr5:5051105-5051235 | MCF10A-Er-Src | breast: | n/a | chr5:5051124-5051132 chr5:5051123-5051133 chr5:5051122-5051134 chr5:5051123-5051133 chr5:5051123-5051133 chr5:5051123-5051133 |
11 | JUN | chr5:5052065-5052247 | K562 | blood: | n/a | n/a |
12 | JUND | chr5:5055519-5055765 | HepG2 | liver: | n/a | n/a |
13 | KAP1 | chr5:5057319-5057938 | HEK293 | kidney: | n/a | n/a |
14 | MAFF | chr5:5055849-5056205 | HepG2 | liver: | n/a | n/a |
15 | MAFF | chr5:5055862-5056162 | K562 | blood: | n/a | n/a |
16 | MAFK | chr5:5055869-5056186 | K562 | blood: | n/a | n/a |
17 | MAFK | chr5:5055843-5056206 | HepG2 | liver: | n/a | n/a |
18 | MAFK | chr5:5055848-5056157 | Hela-S3 | cervix: | n/a | n/a |
19 | MAFK | chr5:5060396-5060704 | HepG2 | liver: | n/a | chr5:5060553-5060573 chr5:5060555-5060571 chr5:5060552-5060567 |
20 | MAFK | chr5:5060531-5060619 | HepG2 | liver: | n/a | chr5:5060553-5060573 chr5:5060555-5060571 chr5:5060552-5060567 |
21 | MAFK | chr5:5055839-5056209 | HepG2 | liver: | n/a | n/a |
22 | MAFK | chr5:5055844-5056213 | IMR90 | lung: | n/a | n/a |
23 | MAFK | chr5:5055888-5056157 | H1-hESC | embryonic stem cell: | n/a | n/a |
24 | POLR2A | chr5:5056666-5056704 | A549 | lung: | n/a | n/a |
25 | POLR2A | chr5:5056719-5056727 | A549 | lung: | n/a | n/a |
26 | POLR2A | chr5:5056651-5056662 | A549 | lung: | n/a | n/a |
27 | POLR2A | chr5:5058014-5058069 | HUVEC | blood vessel: | n/a | n/a |
28 | POLR2A | chr5:5056731-5056733 | A549 | lung: | n/a | n/a |
29 | POLR2A | chr5:5055239-5055330 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | RFX5 | chr5:5055968-5056066 | HepG2 | liver: | n/a | n/a |
31 | RUNX3 | chr5:5056413-5056866 | GM12878 | blood: | n/a | n/a |
32 | SETDB1 | chr5:5052704-5053057 | U2OS | brain: | n/a | n/a |
33 | STAT3 | chr5:5050994-5051383 | MCF10A-Er-Src | breast: | n/a | n/a |
34 | STAT3 | chr5:5051000-5051399 | MCF10A-Er-Src | breast: | n/a | n/a |
35 | STAT3 | chr5:5051001-5051344 | MCF10A-Er-Src | breast: | n/a | n/a |
36 | TCF7L2 | chr5:5057458-5057583 | Hela-S3 | cervix: | n/a | n/a |
37 | USF1 | chr5:5056847-5056993 | K562 | blood: | n/a | n/a |
38 | USF2 | chr5:5057004-5057021 | H1-hESC | embryonic stem cell: | n/a | n/a |
39 | ZNF263 | chr5:5057260-5057947 | HEK293-T-REx | kidney: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:5057500-5057550 | HCT-116 | colon: | n/a |
2 | chr5:5057500-5057550 | GM12891 | blood: | n/a |
3 | chr5:5057500-5057550 | T-47D | breast: | n/a |
4 | chr5:5057500-5057550 | RPTEC | kidney: | n/a |
5 | chr5:5057500-5057550 | HMEC | breast: | n/a |
6 | chr5:5057500-5057550 | Hela-S3 | cervix: | n/a |
7 | chr5:5057500-5057550 | SK-N-MC | brain: | n/a |
8 | chr5:5057500-5057550 | PANC-1 | pancreas: | n/a |
9 | chr5:5057500-5057550 | PFSK-1 | brain: | n/a |
10 | chr5:5057500-5057550 | PrEC | prostate: | n/a |
11 | chr5:5057500-5057550 | MCF-7 | breast: | n/a |
12 | chr5:5057500-5057550 | IMR90 | lung: | fetal |
13 | chr5:5057500-5057550 | NB4 | blood: | n/a |
14 | chr5:5057500-5057550 | NHDF-neo | bronchial: | n/a |
15 | chr5:5057500-5057550 | HRPEpiC | eye: | n/a |
16 | chr5:5057500-5057550 | Hepatocyte | liver: | n/a |
17 | chr5:5057500-5057550 | BE2_C | brain: | n/a |
18 | chr5:5057500-5057550 | ECC-1 | luminal epithelium: | n/a |
19 | chr5:5057500-5057550 | ovcar-3 | ovarian: | n/a |
20 | chr5:5057500-5057550 | K562 | blood: | n/a |
21 | chr5:5057500-5057550 | GM19239 | blood: | n/a |
22 | chr5:5057500-5057550 | HIPEpiC | eye: | n/a |
23 | chr5:5057500-5057550 | AG09309 | skin: | n/a |
24 | chr5:5057500-5057550 | HCF | heart: | n/a |
25 | chr5:5057500-5057550 | LNCaP | prostate: | n/a |
26 | chr5:5057500-5057550 | HNPCEpiC | eye: | n/a |
27 | chr5:5057500-5057550 | GM12878 | blood: | n/a |
28 | chr5:5057500-5057550 | HAEpiC | amniotic membrane: | n/a |
29 | chr5:5057500-5057550 | SK-N-SH_RA | brain: | n/a |
30 | chr5:5057500-5057550 | AG04450 | lung: | fetal |
31 | chr5:5057500-5057550 | AoSMC | blood vessel: | n/a |
32 | chr5:5057500-5057550 | AG10803 | skin: | n/a |
33 | chr5:5057500-5057550 | BJ | skin: | n/a |
34 | chr5:5057500-5057550 | HPAEpiC | pulmonary alveolar: | n/a |
35 | chr5:5057500-5057550 | SAEC | small airway: | n/a |
36 | chr5:5057500-5057550 | HRCEpiC | kidney: | n/a |
37 | chr5:5057500-5057550 | HepG2 | liver: | n/a |
38 | chr5:5057500-5057550 | GM06990 | blood: | n/a |
39 | chr5:5057500-5057550 | HEK293 | kidney: | embryo |
40 | chr5:5057500-5057550 | AG09319 | gingival: | n/a |
41 | chr5:5057500-5057550 | SKMC | muscle: | n/a |
42 | chr5:5057500-5057550 | HCM | heart: | n/a |
43 | chr5:5057500-5057550 | AG04449 | skin: | fetal |
44 | chr5:5057500-5057550 | U87 | brain: | n/a |
45 | chr5:5057500-5057550 | HRE | kidney: | n/a |
46 | chr5:5057500-5057550 | A549 | lung: | n/a |
47 | chr5:5057500-5057550 | Caco-2 | colon: | n/a |
48 | chr5:5057500-5057550 | NHBE | bronchial: | n/a |
49 | chr5:5057500-5057550 | H1-hESC | embryonic stem cell: | embryo |
50 | chr5:5057500-5057550 | GM12892 | blood: | n/a |
(count:2 , 50 per page) page:
1
(count:18 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ADAMTS16-1 | chr5:5051321-5051328 | XLOC_004269 |
2 | lnc-ADAMTS16-1 | chr5:5057675-5057941 | XLOC_004269 |
3 | lnc-ADAMTS16-1 | chr5:5059677-5059794 | XLOC_004269 |
4 | lnc-ADAMTS16-1 | chr5:5057675-5057941 | XLOC_004269 |
5 | lnc-ADAMTS16-1 | chr5:5059677-5059794 | ENSG00000215231 |
6 | lnc-ADAMTS16-1 | chr5:5059677-5059794 | XLOC_004269 |
7 | lnc-ADAMTS16-1 | chr5:5059677-5059794 | XLOC_004269 |
8 | lnc-ADAMTS16-1 | chr5:5059677-5059794 | XLOC_004269 |
9 | lnc-ADAMTS16-1 | chr5:5059677-5059794 | NONHSAT100155 |
10 | lnc-ADAMTS16-1 | chr5:5051321-5051369 | ENSG00000215231 |
11 | lnc-ADAMTS16-1 | chr5:5057675-5057941 | ENSG00000215231 |
12 | lnc-ADAMTS16-1 | chr5:5057675-5057941 | XLOC_004269 |
13 | lnc-ADAMTS16-1 | chr5:5057844-5057941 | XLOC_004269 |
14 | lnc-ADAMTS16-1 | chr5:5057675-5057941 | ENSG00000215231 |
15 | lnc-ADAMTS16-1 | chr5:5057675-5057941 | NONHSAT100155 |
16 | lnc-ADAMTS16-1 | chr5:5059677-5059794 | ENSG00000215231 |
17 | lnc-ADAMTS16-1 | chr5:5057675-5057986 | XLOC_004269 |
18 | lnc-ADAMTS16-1 | chr5:5051321-5051369 | XLOC_004269 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000251426 | TF binding region |
LINC01020 | TF binding region |
ENSG00000251426 | CpG island |
LINC01020 | CpG island |
UBE4A | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs272190 | chr5:5050830-5050831 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs272191 | chr5:5050876-5050877 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs568851200 | chr5:5050877-5050878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs537993179 | chr5:5050891-5050892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs557434965 | chr5:5050954-5050955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs150606542 | chr5:5050981-5050982 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs540055594 | chr5:5050998-5050999 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs272192 | chr5:5051063-5051064 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs573628108 | chr5:5051112-5051113 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs542642597 | chr5:5051113-5051114 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs374883105 | chr5:5051160-5051161 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs272193 | chr5:5051165-5051166 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs531706204 | chr5:5051185-5051186 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs532989724 | chr5:5051196-5051197 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs550035527 | chr5:5051391-5051392 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs375511527 | chr5:5051420-5051421 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs35700881 | chr5:5051447-5051448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs398064468 | chr5:5051450-5051451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs201842087 | chr5:5051451-5051452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs565385733 | chr5:5051456-5051457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs272194 | chr5:5051464-5051465 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs548030683 | chr5:5051465-5051466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs561542156 | chr5:5051466-5051467 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs530457933 | chr5:5051497-5051498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs548699079 | chr5:5051565-5051566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs568789233 | chr5:5051637-5051638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs372056132 | chr5:5051649-5051650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs537453133 | chr5:5051672-5051673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs79957611 | chr5:5051673-5051674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs75028984 | chr5:5051696-5051697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs397763395 | chr5:5051697-5051698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs571033350 | chr5:5051711-5051712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs533717695 | chr5:5051724-5051725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs553587387 | chr5:5051726-5051727 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs539003677 | chr5:5051764-5051765 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs573845965 | chr5:5051783-5051784 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs16874637 | chr5:5051784-5051785 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs139697560 | chr5:5051820-5051821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528981175 | chr5:5051852-5051853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs189610043 | chr5:5051888-5051889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs575684906 | chr5:5052010-5052011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs576343121 | chr5:5052041-5052042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs544252505 | chr5:5052095-5052096 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs143855312 | chr5:5052219-5052220 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs540224879 | chr5:5052293-5052294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs75445252 | chr5:5052312-5052313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs182257167 | chr5:5052396-5052397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs561513789 | chr5:5052397-5052398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs530234205 | chr5:5052430-5052431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs373788396 | chr5:5052475-5052476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 22286061 | CNVD |
Lung cancer | 21911935 | CNVD |
Cri-du chat syndrome | 21549014 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Developmental delay | 21147756 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Melanoma | 22183965 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Schizophrenia | 23813976 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:5050800-5051200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr5:5051200-5066400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr5:5055000-5055200 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr5:5055000-5055200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr5:5055200-5055600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr5:5055200-5056600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr5:5055600-5056000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr5:5056000-5056200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
9 | chr5:5056200-5057200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr5:5056400-5056800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr5:5056400-5057000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
12 | chr5:5056600-5056800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
13 | chr5:5056600-5056800 | Enhancers | Ovary | ovary |
14 | chr5:5056800-5057200 | Weak transcription | Ovary | ovary |
15 | chr5:5056800-5062200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
16 | chr5:5057200-5058000 | Active TSS | Ovary | ovary |
17 | chr5:5057200-5058800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
18 | chr5:5057400-5057600 | Bivalent/Poised TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
19 | chr5:5057400-5057800 | Bivalent Enhancer | Breast Myoepithelial Primary Cells | Breast |
20 | chr5:5057400-5058000 | Bivalent/Poised TSS | Foreskin Keratinocyte Primary Cells skin02 | Skin |
21 | chr5:5057600-5057800 | Flanking Bivalent TSS/Enh | Foreskin Keratinocyte Primary Cells skin03 | Skin |
22 | chr5:5057600-5058000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
23 | chr5:5057600-5058000 | Enhancers | Fetal Kidney | kidney |
24 | chr5:5057800-5058000 | Bivalent Enhancer | Foreskin Keratinocyte Primary Cells skin03 | Skin |
25 | chr5:5058000-5064400 | Weak transcription | Fetal Kidney | kidney |